Inventor

ALINA SILINA

Inventor

Overview

3→

Patents

2022–2025

Patent span

Human necessities

Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes19%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

C07DHeterocyclic compounds19%

A61JContainers specially adapted for medical or pharmaceutical purposes13%

Y02ATechnologies for adaptation to climate change13%

C07BGeneral methods of organic chemistry6%

C07CAcyclic or carbocyclic compounds6%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%

PatentTitleYear

12,421,251Cystic fibrosis transmembrane conductance regulator modulating agents2025 12,168,009Modulators of cystic fibrosis transmembrane conductance regulator2024 11,426,407Modulators of cystic fibrosis transmembrane conductance regulator2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to VERTEX PHARMA (3)· patent assignee history

2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VERTEX PHARMA	3	2022–2025

Locations

Location	Patents	Span
US	3	2022–2025